Skip to main content

Table 2 Univariate and multivariate analysis of clinicopathological factors associated with OS (n = 63)

From: TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

Clinicopathological

Univariate Analysis

Multivariate Analysis

 

HR (95% CI)

P value

HR (95% CI)

P value

Age

1.018

0.398

1.005

0.835

  (< 60 vs ≥ 60)

(0.977–1.060)

 

(0.963–1.048)

Gender

0.623

0.308

0.377

0.119

  (Female vs Male)

(0.251–1.546)

 

(0.111–1.283)

Grade

1.756

0.445

0.189

0.069

  (Low vs High)

(0.414–7.440)

 

(0.031–1.142)

T

2.174

0.041

2.066

0.431

  (T1-T2 vs T3-T4)

(1.032–4.578)

 

(0.340–12.558)

N

2.889

0.042

2.199

0.259

  (N0 vs N1)

(1.041–8.018)

 

(0.559–8.639)

Stage

3.647

0.007

1.927

0.549

  (I-II vs III-IV)

(1.435–9.269)

 

(0.226–16.442)

TEAD4 Expression

4.112

0.002

3.786

0.015

  (Low vs High)

(1.673–10.106)

(1.292–11.091)

  1. Abbreviations: HR Hazard ratio, CI Confidence interval
  2. Numbers in bold indicate p value with statistical significance